• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Veradigm Launches Smart Medicine Podcast to Explore the Evolution of Healthcare

    6/5/25 8:01:00 AM ET
    $MDRX
    EDP Services
    Technology
    Get the next $MDRX alert in real time by email

    Podcast supports company's mission to transform health insightfully, offering expert perspectives and proven strategies to help improve outcomes and reduce costs

    Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today launched the Smart Medicine Podcast, hosted by renowned podcaster and orthopedic surgeon, Dr. Scott Sigman. The show will provide insights and inspiration for clinicians along with other healthcare professionals, as well as payer and life science industry leaders striving to navigate the complexities of modern medicine through incremental insight.

    The podcast features expert guests including physicians, entrepreneurs, business leaders, and healthcare innovators – who will share their journeys, discuss challenges, and reveal the strategies that enable them to thrive. Through in-depth discussions, Smart Medicine will explore how providers are leveraging both time-tested and emerging strategies to enhance patient care, optimize business operations, and shape the future of healthcare. Future episode topics will include value-based care, medical entrepreneurship, point of care innovation, clinical and operational workflow practice management, revenue cycle management, patient and staff engagement and satisfaction, the impact of government and regulation on private practice, and the business of healthcare.

    "By highlighting the real-world challenges, stakes, and rewards of these innovations, Smart Medicine will serve as a trusted guide for those navigating the intersection of medicine and business," said Ray Joske, VP of Marketing at Veradigm. "Each episode will follow an inspirational arc, spotlighting the obstacles overcome, the lessons learned, and the transformative impact of doing healthcare right."

    Dr. Sigman is a nationally and internationally recognized leader in opioid-sparing surgery, with over 25 years of clinical experience as an orthopedic surgeon specializing in knee and shoulder procedures. Widely respected in professional education and medical device development, he has authored numerous peer-reviewed publications, and his TEDx talk on the evolution of the opioid crisis has been widely acclaimed within the industry. His podcast The Ortho Show became a go-to source for the latest in orthopedic news, growing to reach more than 8,000 listeners monthly, with more than 250 episodes.

    Click here to listen to new episodes of Smart Medicine.

    About Veradigm®

    Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube.

    © 2025 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250605856397/en/

    Investors:

    Jenny Gelinas

    312-506-1237

    [email protected]

    Media:

    Amanda Cohen

    412-919-2417

    [email protected]

    Get the next $MDRX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MDRX

    DatePrice TargetRatingAnalyst
    3/19/2024$15.00 → $10.00Buy → Hold
    Deutsche Bank
    1/3/2024$11.00Equal Weight
    Barclays
    7/6/2023Buy → Hold
    Argus
    4/12/2023$13.00Equal-Weight
    Stephens
    2/1/2023$17.00 → $18.50Overweight → Neutral
    Piper Sandler
    12/7/2022$26.00Hold → Buy
    Argus
    11/9/2022$22.00 → $23.00Neutral → Buy
    Goldman
    11/4/2022$17.00Overweight
    Piper Sandler
    More analyst ratings